DR PLANT植物医生IPO进度更新，以科技力与品牌力冲刺A股上市

Core Insights - The company, DR PLANT, has officially initiated its IPO process on the A-share main board, marking a significant step in its capital expansion journey [1] Group 1: Brand Positioning and Competitive Advantage - DR PLANT focuses on a strategic positioning of "high mountain plants, pure beauty," creating a differentiated advantage in the competitive cosmetics market [3] - The brand's core competitiveness is built on a robust R&D system, collaborating with the Kunming Institute of Botany to establish a comprehensive research network [3][6] - The extraction and application of Dendrobium polysaccharides exemplify the company's technological strength, with innovations leading to a key ingredient that promotes collagen production [3] Group 2: Retail Network and Market Presence - As of June 2025, DR PLANT has opened 4,269 offline stores globally, enhancing user engagement and brand experience through face-to-face service [5] - The company has consistently ranked first in retail sales among single-brand cosmetics stores in China, showcasing its significant advantage in offline channels [5] Group 3: Intellectual Property and Innovation - By October 2025, DR PLANT has obtained 223 patents, including 68 invention patents, demonstrating its capability to convert high mountain plant resources into competitive skincare ingredients [6] Group 4: Brand Philosophy and ESG Commitment - The brand philosophy of "respecting nature, valuing science, and giving back to society" is integrated into the company's operations, aligning with contemporary consumer emotional needs [8] - The updated IPO inquiry response highlights DR PLANT's comprehensive strength as a leader in high mountain plant skincare, with a synergistic operational framework across R&D, product matrix, channel network, and brand philosophy [8]